The association between galectin-3 and occurrence of reinfarction early after first myocardial infarction treated invasively.
Galectin-3, as a biomarker of inflammation and fibrosis, has been reported to be associated with coronary artery disease. The study aimed to assess the relationship between galectin-3 levels and the occurrence of reinfarction early after myocardial infarction (MI). The study included 145 consecutive patients with first MI treated invasively. Serum galectin-3 was measured using VIDAS (bioMérieux, Marcy-l'Etoile, France). The independent predictors of reinfarction in our group were as follows: female gender, elevated hs-C-reactive protein and galectin-3 levels (measured both at discharge). Galectin-3 might be an additional useful biomarker in prediction for reinfarction early after first MI.